CUBT
Price:
$0.0087
Market Cap:
$7.86M
Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504...[Read more]
Industry
Biotechnology
IPO Date
1998-03-30
Stock Exchange
PNK
Ticker
CUBT
According to Curative Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.87. This represents a change of -78.39% compared to the average of -4.03 of the last 4 quarters.
The mean historical PE Ratio of Curative Biotechnology, Inc. over the last ten years is -1.29. The current -0.87 PE Ratio has changed 6.63% with respect to the historical average. Over the past ten years (40 quarters), CUBT's PE Ratio was at its highest in in the March 2020 quarter at 3.28. The PE Ratio was at its lowest in in the June 2020 quarter at -469.53.
Average
-1.29
Median
-1.72
Minimum
-4.88
Maximum
2.54
Discovering the peaks and valleys of Curative Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 2.54
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -4.88
Year | PE Ratio | Change |
---|---|---|
2023 | -2.42 | 18.78% |
2022 | -2.04 | -58.16% |
2021 | -4.88 | 130.92% |
2020 | -2.11 | -196.55% |
2019 | 2.19 | -302.76% |
2018 | -1.08 | -23.17% |
2017 | -1.40 | -62.15% |
2016 | -3.71 | -246.23% |
2015 | 2.54 | Infinity% |
2014 | 0 | 0% |
The current PE Ratio of Curative Biotechnology, Inc. (CUBT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.11
5-year avg
-1.85
10-year avg
-1.29
Curative Biotechnology, Inc.’s PE Ratio is greater than Biotron Limited (-4.24), less than Bioasis Technologies Inc. (0), greater than Covalon Technologies Ltd. (-111.00), greater than Mosaic ImmunoEngineering Inc. (-23.07), greater than Ceapro Inc. (-2.99), greater than Cellectis S.A. (-2.93), greater than Resverlogix Corp. (-1.28), greater than Small Pharma Inc. (-2.20),
Company | PE Ratio | Market cap |
---|---|---|
-4.24 | $11.30M | |
0 | $284.08K | |
-111.00 | $72.60M | |
-23.07 | $7.24M | |
-2.99 | $13.31M | |
-2.93 | $183.12M | |
-1.28 | $11.23M | |
-2.20 | $37.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curative Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Curative Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Curative Biotechnology, Inc.'s PE Ratio?
How is the PE Ratio calculated for Curative Biotechnology, Inc. (CUBT)?
What is the highest PE Ratio for Curative Biotechnology, Inc. (CUBT)?
What is the 3-year average PE Ratio for Curative Biotechnology, Inc. (CUBT)?
What is the 5-year average PE Ratio for Curative Biotechnology, Inc. (CUBT)?
How does the current PE Ratio for Curative Biotechnology, Inc. (CUBT) compare to its historical average?